注射用奥美拉唑钠

AnHui BBCA Pharmaceutical Co., Ltd.?is found in 1960s?and?was listed in Sep 4, 2000 in Shenzhen stock Exchange after obtaining the approval of China Securities Regulatory Commission. Up to the end of 2008, the company had more than 4500 employees and a total capital of about 18.25 billion RMB.?BBCA Pharmaceuticals is constituted of three systems which are pharmaceutical R&D, production, and sale. It has 5 pharmaceutical plants and 45 GMP certified production line, mainly involving R&D, production and sale of biological pharmacy, chemical pharmacy, and traditional Chinese medicine,and possessing nine classes of products including antipyretic-analgesic drug, cardiovascular drug, antibiotic, nervous system drug,anti-tumor drug, antiulcer drug, hormones drug, nutriceutical,and preparation of traditional Chinese medicine,etc.?Depending on BBCA advanced technology and abundant strength, BBCA Pharm exports products to all over the world, including Europe, North America, Africa, Southeast Asia and Central Asia.?